Effect of the anorectic drug, phenylpropanolamine, on blood glucose in rats.
Phenylpropanolamine hydrochloride (PPA) is a widely used decongestant and anorectic drug. The present study investigated the hypoglycemic effects of intraperitoneal PPA on rats to test the possibility that it might derive some of its anorectic properties through effects on glucostatic mechanisms. PPA tended to lower blood glucose levels in normal rats; the glycemia reducing effect was larger and statistically significant in rats made hyperglycemic by prior treatment with streptozocin to cause diabetes. This is the first evidence that PPA migh possibly reduce feeding by increasing blood sugar utilization.
D000818:Animals; D001067:Appetite Depressants / Q000008:administration & dosage / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism*; D003864:Depression, Chemical; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D005260:Female; D007274:Injections, Intraperitoneal; D010665:Phenylpropanolamine / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats
D001067:Appetite Depressants; D001786:Blood Glucose; D010665:Phenylpropanolamine